Oaktree Acquisition Corp. III Life Sciences (OACC) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -158.03K | -56.52K | -132K | -89.69K | 0 |
| Operating CF Margin % | - | - | - | - | - |
| Operating CF Growth % | - | - | - | - | - |
| Net Income | 1.39M | 1.97M | 2.15M | 1.38M | -48.09K |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.55M | -2.02M | -2.07M | -1.68M | 41.16K |
| Working Capital Changes | 0 | 0 | -214.02K | 214.02K | 6.93K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 249.5K | 32.55K | -153.96K | 0 | 0 |
| Cash from Investing | 0 | 191.99M | 250K | -191.99M | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investments | 203.41M | 199.77M | 197.58M | 193.58M | 0 |
| Other Investing | 0 | 0 | 250K | 0 | 0 |
| Cash from Financing | 0 | -193.44M | 0 | 193.44M | 0 |
| Debt Issued (Net) | - | - | - | - | - |
| Equity Issued (Net) | 0 | 0 | 0 | 193.99M | 0 |
| Dividends Paid | 0 | -4.25M | -4.25M | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -189.19M | 4.25M | 0 | 0 |
| Net Change in Cash | -158.03K | -56.52K | 28.32K | 1.36M | 0 |
| Free Cash Flow | -158.03K | -56.52K | -132K | -89.69K | 0 |
| FCF Margin % | - | - | - | - | - |
| FCF Growth % | - | - | - | - | - |
| FCF per Share | -0.01 | -0.00 | -0.01 | -0.00 | - |
| FCF Conversion (FCF/Net Income) | -0.11x | -0.03x | -0.07x | -0.07x | - |
| Interest Paid | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |